J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM.NS Stock
J. B. Chemicals & Pharmaceuticals Limited Price Chart
J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM.NS Financial and Trading Overview
Contents
- J. B. Chemicals & Pharmaceuticals Limited Price Chart
- J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM.NS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of J. B. Chemicals & Pharmaceuticals Limited
- Q&A For J. B. Chemicals & Pharmaceuticals Limited Stock
| J. B. Chemicals & Pharmaceuticals Limited stock price | 1804.6 INR |
| Previous Close | 2161.8 INR |
| Open | 2168.15 INR |
| Bid | 2239.15 INR x 0 |
| Ask | 2245 INR x 0 |
| Day's Range | 2154.05 - 2245 INR |
| 52 Week Range | 1402.7 - 2245 INR |
| Volume | 204.58K INR |
| Avg. Volume | 80.5K INR |
| Market Cap | 173.56B INR |
| Beta (5Y Monthly) | -0.076369 |
| PE Ratio (TTM) | 42.907177 |
| EPS (TTM) | 32.58 INR |
| Forward Dividend & Yield | 18.5 (0.85%) |
| Ex-Dividend Date | August 16, 2023 |
| 1y Target Est | N/A |
JBCHEPHARM.NS Valuation Measures
| Enterprise Value | 171.4B INR |
| Trailing P/E | 42.907177 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.511131 |
| Price/Book (mrq) | 6.990798 |
| Enterprise Value/Revenue | 5.442 |
| Enterprise Value/EBITDA | 24.635 |
Trading Information
J. B. Chemicals & Pharmaceuticals Limited Stock Price History
| Beta (5Y Monthly) | -0.076369 |
| 52-Week Change | 50.26% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2245 INR |
| 52 Week Low | 1402.7 INR |
| 50-Day Moving Average | 2080.73 INR |
| 200-Day Moving Average | 1999.2 INR |
JBCHEPHARM.NS Share Statistics
| Avg. Volume (3 month) | 80.5K INR |
| Avg. Daily Volume (10-Days) | 36.12K INR |
| Shares Outstanding | 77.42M |
| Float | 33.89M |
| Short Ratio | N/A |
| % Held by Insiders | 54.31% |
| % Held by Institutions | 22.71% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 17.75 |
| Trailing Annual Dividend Yield | 0.82% |
| 5 Year Average Dividend Yield | 98.00% |
| Payout Ratio | 0.3152 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 13.01% |
| Operating Margin (ttm) | 18.45% |
| Gross Margin | 62.90% |
| EBITDA Margin | 22.09% |
Management Effectiveness
| Return on Assets (ttm) | 11.79% |
| Return on Equity (ttm) | 17.75% |
Income Statement
| Revenue (ttm) | 31.49B INR |
| Revenue Per Share (ttm) | 407.27 INR |
| Quarterly Revenue Growth (yoy) | 22.10% |
| Gross Profit (ttm) | 19.81B INR |
| EBITDA | 6.96B INR |
| Net Income Avi to Common (ttm) | 4.1B INR |
| Diluted EPS (ttm) | 52.25 |
| Quarterly Earnings Growth (yoy) | 3.30% |
Balance Sheet
| Total Cash (mrq) | 2.71B INR |
| Total Cash Per Share (mrq) | 35.04 INR |
| Total Debt (mrq) | 5.72B INR |
| Total Debt/Equity (mrq) | 23.08 INR |
| Current Ratio (mrq) | 2.756 |
| Book Value Per Share (mrq) | 320.693 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 6.26B INR |
| Levered Free Cash Flow (ttm) | -2484334592 INR |
Profile of J. B. Chemicals & Pharmaceuticals Limited
| Country | India |
| State | N/A |
| City | Mumbai |
| Address | Cnergy IT Park |
| ZIP | 400025 |
| Phone | 91 22 2439 5200 |
| Website | https://www.jbpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.
Q&A For J. B. Chemicals & Pharmaceuticals Limited Stock
What is a current JBCHEPHARM.NS stock price?
J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM.NS stock price today per share is 1804.6 INR.
How to purchase J. B. Chemicals & Pharmaceuticals Limited stock?
You can buy JBCHEPHARM.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for J. B. Chemicals & Pharmaceuticals Limited?
The stock symbol or ticker of J. B. Chemicals & Pharmaceuticals Limited is JBCHEPHARM.NS.
Which industry does the J. B. Chemicals & Pharmaceuticals Limited company belong to?
The J. B. Chemicals & Pharmaceuticals Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does J. B. Chemicals & Pharmaceuticals Limited have in circulation?
The max supply of J. B. Chemicals & Pharmaceuticals Limited shares is 155.26M.
What is J. B. Chemicals & Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
J. B. Chemicals & Pharmaceuticals Limited PE Ratio is 55.38980500 now.
What was J. B. Chemicals & Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
J. B. Chemicals & Pharmaceuticals Limited EPS is 32.58 INR over the trailing 12 months.
Which sector does the J. B. Chemicals & Pharmaceuticals Limited company belong to?
The J. B. Chemicals & Pharmaceuticals Limited sector is Healthcare.